News and Comments

COULD AGENUS VACCINE FOR GLIOBLASTOMA BE ASSIGNED BREAKTHROUGH DESIGNATION?

  Tuesday, September 17, 2013

AGENUS (AGEN) has extraordinary news. A recent analysis from a Phase 2 trial in patients with newly diagnosed glioblastoma multiforme (GBM) treated with Prophage Series G-100 (HSPPC-96) in combination with the current standard of care (radiation and temozolomide) showed an almost 18 month median progression free survival (PFS), which represents a 160% increase versus current standard of care alone. The results confirm continuation of the positive trends from the Phase 2 HSPPC-96 newly diagnosed GBM trial first reported at the 81st American Association of Neurological Surgeons (AANS) Annual Scientific Meeting in May 2013. More...


Recent Postings


Archive


Tags

ZALTRAP™ ARCA (ABIO) Endometrial Cancer Alder Biopharmaceuticals (ALDR) Ionis (IONS) Ariad (ARIA) Sangamo (SGMO) Bristol-Myers Squibb (BMY) Incyte (INCY) Genentech NANTKWEST (NK) IDERA (IDRA) C4 Therapeutics REGULUS (RGLS) Xoma (XOMA) Intercept (ICPT) ISIS (ISIS) Intermune (ITMN) Elan (ELN) Exelixis (EXEL) Galena (GALE) Sarepta (SRPT) Roche (ROCHE) Sequenom (SQNM) Amgen (AMGN) Abbott Laboratories (ABT) Prolor Biotech (PBTH) ImmunoGen (IMGN) Telaprevir Idenix (IDIX) ACADIA (ACAD) Herceptin Benlysta (belimumab) Roche (RHHBY) Dynavax (DVAX) Onyx (ONXX) GlaxoSmithKline (GSK) GUARDIAN HEALTH Anadys (ANDS) Regeneron (REGN) Biogen Idec (BIIB) Inovio (INO) SUNESIS PHARMACEUTICALS (SNSS) VANDA (VNDA) Agenus (AGEN) Aimmune Therapeutics (AIMT) Multiple Myeloma Velcade (bortezomib) ABBVIE (ABBV) JUNO (JUNO) SYNTA (SNTA) Pluristem (PSTI) HALOZYME (HALO) Illumina (ILMN) Revlimid (lenolidamide) BIOMARIN (BMRN) Ziofpharm (ZIOP) Gilead (GILD) Ridaforolimus Biocryst (BCRX) Merck (MRK) Editas (EDIT) Tysabri Array Pharmaceuticals (ARRY) Valeant Pharmaceuticals International (VRX) ADVENTRIX (ANX) Auspex (ASPX) CompuGen (CGEN) Theravance Bio Pharma (TBPH) PTC Therapeutics (PTCT) KERYX (KERX) Vertex (VRTX) Alnylam (ALNY) TOKAI (TKAOI) RenenxBio (RGNX) Seattle Genetics (SGEN) AERIE PHARMACEUTICALS Sanofi-Aventis (SAN) Micromet (MITI) OSI (OSIP) Theravance (THRX) Anacor (ANAC) Human Genome Sciences (HGSI) Mirati Therapeutics (MRTX) Vitae Pharmaceuticals (VTAE) Trastuzumab-DM1 Sanofi (SNY) Jazz Pharmaceuticals (JAZZ) NEKTAR (NKTR)) Human Longevity (HLI) Prosensa (RNA) Sanofi (SNA) galapagos (GLPG) KITE (KITE) SERES THERAPEUTICS (MCRB) Rapamune Zerenex Dendreon (DNDN) Intrexon (XON) Agenus (AGEN Cytokinetics (CYTK)